KOLMAR-BNH
28.5.2024 15:01:28 CEST | Business Wire | Press release
Kolmar BNH (KRX: 200130), a prominent Korean health functional food Original Development Manufacturing (ODM) firm, announced that it has unveiled its latest offering, HemoHIM G, in Taiwan. This introduction is part of the company's endeavor to expand its presence in global markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240527924165/en/
Manufactured by Kolmar BNH and distributed by Atomy, HemoHIM G, containing Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora, is now available in Taiwan. (Photo: Kolmar BNH)
HemoHIM G represents an enhanced iteration of HemoHIM, tailored to meet the distinctive tastes of consumers in Taiwan and Europe.
Kolmar BNH plans to expedite its market expansion in Asia by launching HemoHIM G in the Taiwan market on May 15. HemoHIM G, tailored for international export, has made meticulous adjustments in raw materials and ingredient proportions to comply with varying food regulations across different jurisdictions. Key ingredients such as Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora went through rigorous sourcing procedures, accompanied by stringent quality control measures. The taste and aroma profiles were tailored to suit the preferences of European consumers.
Furthermore, in April, Kolmar BNH's research findings on HemoHIM G were published in the esteemed academic journal 'Toxicological Research,' accredited at the SCIE level. These findings, which adhere to OECD guidelines, hold paramount significance as they not only validate the product's safety for regulatory compliance in diverse markets but also bolster intellectual property rights through reliable results.
HemoHIM, Kolmar BNH's flagship product, is distributed through its partner Atomy. The product has achieved remarkable milestones, surpassing KRW 2 trillion in cumulative sales at home and abroad since its launch. The product's success is attributed to Kolmar BNH's research and development capabilities, coupled with enduring consumer trust built over time.
The product name HemoHIM derives from the fusion of ‘HEMO (hemoglobin)’ and ‘HIM (H: hematopoiesis, I: immunity, and M: modulation)’. It encompasses extracts sourced from natural medicinal herbs such as Angelica gigas, Cnidium officinale, and Paeonia japonica. This accomplishment is a result of the collaborative endeavors of Kolmar BNH, established jointly by the Korea Atomic Energy Research Institute and Kolmar Korea, with a budget of KRW 5 billion over eight years.
Notably, the Korea Atomic Energy Research Institute, an institution concerned with radiation, has reinforced trust in HemoHIM, as it initiated research for self-protection purposes. This collaboration, combined with Kolmar BNH's expertise in commercialization and production technology, culminated in the successful development of a blended substance that enhances immune function.
HemoHIM gained recognition from the Ministry of Food and Drug Safety in 2006 as the first individually recognized functional raw material in Korea for enhancing immune function. It marked a pioneering milestone in functional food development within Korea, particularly at a juncture when research and raw materials for improving immune function were scarce.
Kolmar BNH has been reinforcing reliability through sustained research and development endeavors since the launch of HemoHIM. Consistently allocating more than 2% of its annual sales to R&D initiatives for new developments, the company achieved a significant milestone by integrating fatigue improvement functionality into HemoHIM. This came six years after the 'HemoHIM sustainable technology development project' began in 2017.
Kolmar BNH has grown by leaps and bounds with HemoHIM. In 2015, when it was listed on Korea’s key stock market KOSDAQ, the company posted sales of KRW 236.2 billion, and last year it surged 145% to KRW 579.6 billion.
An official from Kolmar BNH said, "The enduring appeal of HemoHIM among consumers underscores its proven functionality. We will remain steadfast in our commitment to advancing research and development efforts to uphold HemoHIM's status as Korea's premier functional health food."
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240527924165/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ RightLogic to Address Cyber Risk in AI Era6.7.2026 11:12:00 CEST | Press release
New assessment and risk assurance framework helps enterprises gain unified visibility, prioritise remediation and scale AI securely LTM, the Business Creativity partner to the world’s largest enterprises, has launched BlueVerse™ RightLogic, a cybersecurity assessment and risk assurance framework designed to help enterprises identify, assess and remediate cyber exposure as they accelerate AI adoption. AI is now capable of autonomously identifying and exploiting vulnerabilities, while exposure across infrastructure, applications and supply chains continue to expand. This has elevated cyber risk from a technology concern to a board-level priority, with enterprises struggling to maintain visibility and respond at the speed of emerging threats. BlueVerse RightLogic addresses this gap by providing a unified, business-aligned view of enterprise exposure and enabling a shift from fragmented, point-in-time assessments to continuous, evidence-led risk management. The framework combines an end-to
Media Release: Financial Worries Rise and Match Health Concerns as Cost-of-Living Pressures Mount in 20266.7.2026 10:00:00 CEST | Press release
Globally, people are united in their top personal worries: Financial and health issues rank at the top in 2026, averaging 13 percentage points ahead of other concerns.Financial pressure is prominent across Europe, rising in France, Germany, and U.K., and emerging as a top concern in newly measured markets, Spain and Switzerland.Allianz published these results in “The Allianz 3am Report 2026,” which surveyed 10,000 people across 10 countries worldwide about what keeps them awake at night.Addressing financial concerns requires accessible, targeted financial and risk education. To support this, Allianz has launched the “Allianz School For Life” learning platform. Households around the world are feeling the strain of the rising cost of living, with financial pressure increasingly shaping everyday choices and long-term confidence. Finances and health are now tied as the top global worries, at 48% each, followed by concerns about the future at 35%, according to consumer surveys in 10 countri
HAZAMA ANDO Becomes an Official Partner in Helical Fusion’s Commercial Fusion Initiative and Signs MoU Toward Construction of the Fusion Pilot Plant6.7.2026 08:40:00 CEST | Press release
A long-established Japanese general contractor will contribute construction expertise to advance Fusion Pilot Plant development toward commercially viable fusion power. Helical Fusion Co., Ltd. (“Helical Fusion”), a Japan-based fusion energy startup developing fusion power plants, and HAZAMA ANDO CORPORATION (“HAZAMA ANDO”), a long-established Japanese general contractor, today announced that HAZAMA ANDO has become an Official Partner in the Helix Program, Helical Fusion’s commercial fusion initiative. The two companies have also signed a memorandum of understanding (“MoU”) to collaborate toward the construction of Helix KANATA, Helical Fusion’s Fusion Pilot Plant targeted for the 2030s. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706176052/en/ (L-R) Kazuhiko Kuniya (Representative Director and President, HAZAMA ANDO CORPORATION) and Takaya Taguchi (Co-Founder and CEO, Helical Fusion Co., Ltd.) at a press conference in
Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis6.7.2026 07:15:00 CEST | Press release
Sofinnova Partners co-led the seed investment in 2019 and has supported the company from founding through to exitThe proposed acquisition combines the oncology expertise of Novartis with Myricx Bio’s novel ADC assets and platform having broad potential across multiple solid tumor typesMyricx Bio's first-in-class NMTi payload platform is designed to improve the therapeutic index of ADCs, offering the potential for more effective and better-tolerated treatment options for cancer patientsThe transaction valued at up to $1.5 billion including $1.1 billion cash upfront Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to $1.5 billion including $1.1 billion cash upfront plus potential milestone payments. This marks Sofinnova Partners' seventh exit in three years. Myricx Bio is a UK-headquartered transatlantic biotech company focused on the discove
Global New Material International Wins Technology Innovation Best Practice Award at Sino-European ESG Conference6.7.2026 05:59:00 CEST | Press release
Global New Material International Holdings Ltd. has received the Technology Innovation Best Practice Award at the Third Sino-European Corporate ESG Best Practice Conference recently in Mainz, Germany, in recognition of its efforts to advance sustainable development through material innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260705533555/en/ Thorsten Giehler (L), Director of the Economic, Social Development and Employment Division of The German Society for International Cooperation (GIZ), delivered the award to Zhou Fangchao, Executive Director and Vice President of Global New Material International. The annual conference, initiated by the Chinese Consulate General in Frankfurt and jointly organized with Chinese and European partners, recognizes corporate best practices in environmental, social and governance (ESG) performance. This year's event brought together government officials, business leaders and exper
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom